8J3N

Solution NMR structure of purS subunit of phosphoribosylformylglycinamidine synthase enzyme from Staphylococcus aureus

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
2	2D 1H-13C HSQC aliphatic	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
3	2D 1H-13C HSQC aromatic	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
4	3D HNCA	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
5	3D HNCACB	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
6	3D HNCO	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
7	3D HNHA	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
8	3D 1H-13C NOESY aliphatic	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
9	3D 1H-13C NOESY aromatic	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800
10	3D 1H-15N NOESY	1.2 mM 15N,13C Uniformly labeled Subunit PurS of phosphoribosylformylglycinamidine synthase, 20 mM sodium phosphate, 20 mM sodium chloride, 1 mM DTT, 0.03 % sodium azide, 0.15 mM DSS	95% H2O/5% D2O	20 mM	6.0	1 atm	298	Bruker AVANCE III HD 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	800

NMR Refinement
Method	Details	Software
na		MOLMOL

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	18
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CARA	1.8.4.2	Keller and Wuthrich
8	chemical shift assignment	Sparky	3.114	T. D. Goddard and D. G. Kneller
2	peak picking	Sparky	3.114	T. D. Goddard and D. G. Kneller
3	collection	TopSpin	3.5pl7	Bruker Biospin
9	processing	TopSpin	3.5pl7	Bruker Biospin
5	structure calculation	CYANA	3.98.15	Guntert, Mumenthaler and Wuthrich
4	data analysis	TALOS-N	4.12	Yang Shen, and Ad Bax
6	data analysis	MOLMOL		Koradi, Billeter and Wuthrich
7	data analysis	PyMOL		Schrodinger, and DeLano

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.